-
Novel Drug May Increase Bone Growth in Children with Achondroplasia
A first of its kind drug called vosoritide may increase bone growth in children with achondroplasia, the most common form of dwarfism, according to findings from a recent clinical trial.
-
Antibiotic Treatment for Appendicitis Shows Similar Patient Outcomes as Surgery
A nationwide clinical trial has found that patients taking antibiotics for appendicitis reported the same quality of life measures as those who underwent surgery.
-
Utilizing B-Cells to Promote Glioblastoma Immunity
Northwestern investigators have developed a novel vaccine that utilizes a specialized group of B-cells to promote anti-tumor immunity against glioblastoma.
-
Rocklin Receives NIH New Innovator Award
Gabriel Rocklin, PhD, assistant professor of Pharmacology, has received the NIH Director’s New Innovator Award, an early-career grant supporting unconventional research projects in the biomedical, behavioral or social sciences.
-
Source of Rare Intellectual Disability Syndrome Discovered
New findings have revealed previously unknown information about the genetic basis for Armfield XLID syndrome, a rare intellectual disability linked to genetic defects in the X chromosome.
-
Inflammation Linked to Alzheimer’s
A new study provides a missing link between inflammation and protein deposits that contribute to Alzheimer’s disease.
-
New Details on T-Cell Methylation
The DNA methylation landscape of regulatory T-cells is more complex than previously understood, according to a new Northwestern Medicine study.
-
First Year Student Discusses the Medical School Journey
For Elizabeth Adams, a first-year medical student, donning her white coat felt like the culmination of one journey and the beginning of another.
-
‘Snowflake’ Nanoparticle Boosts Cancer Therapy
A snowflake-shaped nanoparticle greatly enhanced the combination of radiotherapy and immunotherapy in mouse models of prostate cancer.
-
Celebrating Medical Education
Feinberg educators celebrated teaching and learning virtually at the tenth annual Medical Education Day.
-
Drug May Delay Progression of Ovarian Cancer
The drug rucaparib significantly delayed cancer progression for women with ovarian cancer and may be an effective option for maintenance therapy, according to findings from a recent clinical trial.
-
New Chemotherapy Alternative for Lymphoma
A new immunotherapy treatment for recurrent B-cell lymphoma was found to be safe in a trial of nearly 350 patients, according to a study published in The Lancet.
-
New Understanding of Leukocyte Migration
A recent Northwestern Medicine study has revealed previously unknown details about calcium signaling that can contribute to inflammation.
-
Earlier Treatment May Reduce Cardiovascular Disease
Starting cholesterol-lowering treatment earlier may increase the its benefits, reducing heart attack and stroke over time, according to a Northwestern Medicine study.
-
Medical School Research Funding Breaks Records in 2020
Feinberg principal investigators secured a record-breaking $643 million in research funding and awards during the 2019-2020 fiscal year.
-
Breast and Ovarian Cancer Drug Extends Prostate Cancer Survival
Men with advanced prostate cancer who were treated based on the genetic makeup of their cancer survived significantly longer than those treated with standard treatments, according to a new study.
-
Protein Paves the Way for Early HIV Infection
Northwestern Medicine investigators have discovered that a specialized protein associated with the microtubules of a cell helps facilitate and regulate early stages of HIV infection.
-
Dermatology Chief Resident Discusses ABC News Internship
Molly Stout, MD, chief resident in the Department of Dermatology, has been interning for ABC News’ Medical Unit through their Resident Rotation Program, helping with writing and reviewing medical news stories for the network’s major TV news stations and website.
-
New Drug Target for Treatment-Resistant Prostate Cancer
Inhibiting an epigenetic regulator called DOT1L could be a key to slowing treatment-resistant prostate cancer, according to a recent Northwestern Medicine study.
-
New Biomarkers for Glioma Treatment Response
Biomarkers using mass cytometry can assess patient response to an emerging treatment for pediatric brain tumors, according to a recent multi-center study.
